School-age outcomes of very low birth weight infants in the indomethacin intraventricular hemorrhage prevention trial

Pediatrics. 2003 Apr;111(4 Pt 1):e340-6. doi: 10.1542/peds.111.4.e340.

Abstract

Objective: The cohort consisted of 328 very low birth weight infants (600-1250 g birth weight) who were enrolled in the low-dose prophylactic indomethacin prevention trial and were intraventricular hemorrhage (IVH) negative at 6 postnatal hours. The objective was to determine the effects of both IVH and indomethacin on cognitive, language, and achievement performance at 8 years of age.

Methods: The cohort was divided into 4 subgroups for analysis: indomethacin plus IVH, indomethacin no IVH, saline plus IVH, and saline with no IVH. The children were evaluated prospectively at 8 years of age with a neurologic assessment, history of school performance, and a battery of cognitive, academic, behavioral, and functional assessments.

Results: Children in both IVH groups had more cerebral palsy; more hearing impairment; lower daily living skills scores; lower IQ, vocabulary, and reading and mathematics achievement test scores; and greater educational resource needs. With logistic regression analyses grade 3 to 4 IVH, periventricular leukomalacia and/or ventriculomegaly, male gender, maternal education, and language spoken in the home contributed to outcomes. No effects of indomethacin or gestational age were identified.

Conclusions: Although biological factors including IVH, ventriculomegaly, and periventricular leukomalacia contribute significantly to school age outcomes among very low birth weight survivors at 8 years of age, social and environmental factors including maternal level of education and primary language spoken in the home are also important contributors to outcome.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cerebral Hemorrhage / prevention & control*
  • Cerebral Palsy / epidemiology
  • Cerebral Ventricles / drug effects*
  • Cerebral Ventricles / pathology*
  • Child
  • Cohort Studies
  • Developmental Disabilities / epidemiology
  • Female
  • Hearing Loss / epidemiology
  • Humans
  • Indomethacin / therapeutic use*
  • Infant
  • Infant, Newborn
  • Infant, Very Low Birth Weight* / physiology
  • Infant, Very Low Birth Weight* / psychology
  • Intelligence Tests / statistics & numerical data
  • Leukomalacia, Periventricular / epidemiology
  • Male
  • Needs Assessment / statistics & numerical data
  • Prospective Studies
  • Regression Analysis

Substances

  • Indomethacin